- 1D
- 3D
- 1W
- 1M
- 6M
- 1Y
- 3Y
- 5Y
Announcements
- Holding(s) in Company
- Attending JPMorgan Conference & Biotech Showcase
- Corporate Update
- IMMUPHARMA ATTENDING BIO-EUROPE
- Launch of Website; Corporate Update
- Appointment of Independent Non-Executive Director
- Exercise of Warrants
- Appointments of CSO and Head of R&D
- ImmuPharma Files New Patent Application for P140:
- Interim Results
More ▼
Key statistics
On Friday, ImmuPharma PLC (IMM:LSE) closed at 6.38, 360.28% above the 52 week low of 1.39 set on Aug 13, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 6.80 |
|---|---|
| High | 6.80 |
| Low | 5.90 |
| Bid | 5.90 |
| Offer | 6.90 |
| Previous close | 6.51 |
| Average volume | 2.35m |
|---|---|
| Shares outstanding | 502.72m |
| Free float | 455.70m |
| P/E (TTM) | -- |
| Market cap | 32.73m GBP |
| EPS (TTM) | -0.0089 GBP |
Data delayed at least 20 minutes, as of Feb 06 2026 16:35 GMT.
More ▼
